Prevention and control of COVID-19

Information on COVID-19 vaccination, vaccine efficacy and effectiveness and prevention and control in long-term care facilities.

COVID-19 vaccination

COVID-19 vaccines are being developed following the same legal requirements for quality, safety and efficacy as for all other vaccines.

Efficacy, effectiveness and safety of vaccines against COVID-19

A living systematic review on the efficacy, effectiveness and safety of COVID-19 vaccines authorised in the EU/EEA

The Response Measures Database (RMD)

The ECDC-JRC database is an archive of non-pharmaceutical interventions (NPIs), or measures, introduced by 30 countries in the European Union and European Economic Area in response to the coronavirus disease (COVID-19) pandemic. The RMD is reviewed and updated every two weeks.

Data

Social contact patterns in the EU/EEA during the COVID-19 pandemic

Data - 27 Sep 2022

This survey (CoMix) was conducted to enhance our understanding of contact mixing during the transition period beyond the acute phase of the COVID-19 pandemic.

Prevention and control of COVID-19

COVID-19 vaccination

Efficacy, effectiveness and safety of vaccines against COVID-19

Long-term care facilities

Read more

The Response Measures Database (RMD)

Social contact patterns in the EU/EEA during the COVID-19 pandemic

All reports on prevention and control

Data collection on COVID-19 outbreaks in closed settings: long-term care facilities, version 2.1

Guidance on ending the isolation period for people with COVID-19, third update

Surveillance of COVID-19 in long-term care facilities in the EU/EEA

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage

Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern

Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

COVID-19 in children and the role of school settings in transmission - second update

Considerations for the use of saliva as sample material for COVID-19 testing

COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic

Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update

Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA

Assessment of the current SARS-CoV-2 epidemiological situation in the EU/EEA, projections for the end-of-year festive season and strategies for response, 17th update

Communicable disease threats report, 6 - 12 June 2021, week 23

Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA

Surveillance of COVID-19 in long-term care facilities in the EU/EEA

Guidance on the provision of support for medically and socially vulnerable populations in EU/EEA countries and the United Kingdom during the COVID-19 pandemic

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

COVID-19 in reception and detention centres for migrants and refugees

Conducting after-action reviews of the public health response to COVID-19: update

ECDC expert consultation on knowledge and research gaps related to the COVID-19 public health response

Assessing the Implementation of Digital Innovations in Response to the COVID-19 Pandemic to Address Key Public Health Functions: Scoping Review of Academic and Nonacademic Literature

Multisystem Inflammatory Syndrome in Children (MIS-C)

Considerations for the use of antibody tests for SARS-CoV-2 – first update

More on this topic

Preparedness for COVID-19

Featured links

Latest

Featured links

Latest

Featured links

Latest

Featured links

Spotlight

Featured links

Spotlight

Prevention and control of COVID-19

COVID-19 vaccination

Efficacy, effectiveness and safety of vaccines against COVID-19

Long-term care facilities

Read more

The Response Measures Database (RMD)

Social contact patterns in the EU/EEA during the COVID-19 pandemic

All reports on prevention and control

Data collection on COVID-19 outbreaks in closed settings: long-term care facilities, version 2.1

Guidance on ending the isolation period for people with COVID-19, third update

Surveillance of COVID-19 in long-term care facilities in the EU/EEA

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage

Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern

Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

COVID-19 in children and the role of school settings in transmission - second update

Considerations for the use of saliva as sample material for COVID-19 testing

COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic

Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update

Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA

Assessment of the current SARS-CoV-2 epidemiological situation in the EU/EEA, projections for the end-of-year festive season and strategies for response, 17th update

Communicable disease threats report, 6 - 12 June 2021, week 23

Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA

Surveillance of COVID-19 in long-term care facilities in the EU/EEA

Guidance on the provision of support for medically and socially vulnerable populations in EU/EEA countries and the United Kingdom during the COVID-19 pandemic

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

COVID-19 in reception and detention centres for migrants and refugees

Conducting after-action reviews of the public health response to COVID-19: update

ECDC expert consultation on knowledge and research gaps related to the COVID-19 public health response

Assessing the Implementation of Digital Innovations in Response to the COVID-19 Pandemic to Address Key Public Health Functions: Scoping Review of Academic and Nonacademic Literature

Multisystem Inflammatory Syndrome in Children (MIS-C)

Considerations for the use of antibody tests for SARS-CoV-2 – first update

More on this topic

Preparedness for COVID-19

Follow us: